French Biotech Breakthroughs

Innate Pharma

Market Cap: €180.8m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Aelis Farma

Market Cap: €16.4m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

MaaT Pharma

Market Cap: €78.8m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Valneva

Market Cap: €464.7m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.